CHECKPOINT FOR B CELL SURVIVAL IN HUMAN GUT
CHECKPOINT FOR B CELL SURVIVAL IN HUMAN GUT
批准号:
MR/P021964/1
负责人:
Jo Spencer
金额:
$54.71万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
B细胞是免疫系统的细胞。B细胞通过B细胞表面非常特殊的受体(称为B细胞受体)识别感染性颗粒来对抗感染。B细胞受体通过它们的个体形状识别感染因子,并以锁与钥匙的方式与它们结合。数以百万计的B细胞在血液和身体组织中循环,每个B细胞都有一个独特的B细胞受体。因此,无论哪种感染因子进入人体,都会有一个具有互补形状受体的B细胞将其结合。如果一个B细胞通过它的B细胞受体与感染粒子结合,B细胞可能被激活并分泌它的B细胞受体,B细胞受体将与感染因子结合并对抗感染因子。当B细胞受体被分泌时,它被称为抗体。产生具有独特受体的大量多样的B细胞的过程有一个主要的相关危险。B细胞可以与人体自身的细胞和组织结合并攻击它们。免疫系统中的另一种叫做T细胞的细胞有能力调节B细胞,它们自己可以很好地区分自我和非自我。然而,许多B细胞可以产生与T细胞无关的反应,如果没有适当的特异性调节,这些反应是特别危险的。以不依赖t细胞的方式激活B细胞的感染因子包括那些引起某些类型肺炎的感染因子。B细胞有一个额外的技巧来识别这些药物,因为它们在表面上有一个重复的形状模式。B细胞可以通过B细胞受体识别形状,也可以识别形状呈现的规律性。我们实验室的实验表明,在肠道中发生的B细胞选择会阻止自身反应,并促进对独立于T细胞的激活B细胞的颗粒的反应。肠道中有很多“友好”细菌,它们会不断刺激肠道内的免疫系统。我们的实验表明,这种环境支持在人类B细胞免疫学模型或人类疾病评估中很大程度上被忽视的B细胞发育阶段。我们称其为“检查点”,因为这是B细胞发育的一个阶段,只有具有所需属性的细胞才被允许通过。在许多物种中,肠道以不同的方式参与了B细胞的发育,包括鸡、老鼠、羊和兔子。因此,肠道对人类B细胞发育的影响是重要的,而且极有可能发生,但迄今为止完全是神秘的。本应用程序中描述的实验目的是了解B细胞如何在肠道中成熟以及如何调节。
英文摘要
B cells are cells of the immune system. B cells fight infections by identifying infectious particles via very specific receptors on the B cell surface, called the B cell receptors. B cell receptors recognise infectious agents by their individual shape and they bind to them in a lock-and-key way. Millions of B cells circulate through the blood and tissues of the body and each B cell has a B cell receptor that is unique to that B cell. As a consequence, no matter what infectious agent finds its way into the body, there will be a B cell with a receptor of the complementary shape to bind it. If a B cell binds to an infectious particle via its B cell receptor, the B cell may become activated and secrete its B cell receptor that will bind to and fight the infectious agent. When the B cell receptor is secreted it is referred to as antibody.The process that generates the huge and diverse set of B cells with unique receptors has a major associated hazard. B cells can be produced that bind to the body's own cells and tissues and can attack them. Other cells of the immune system called T cells have the capacity to regulate B cells and they themselves can discriminate well between self and non-self. However, many B cells can make T cell independent responses and these are particularly dangerous if not properly regulated for specificity.The infectious agents that activate B cells in a T-cell independent way include those that cause some types of pneumonia. B cells have an additional trick to recognise these agents because they have a repeating pattern of shapes on the surface. B cells may be able to recognise the shape through the B cell receptor, but also the regularity with which the shape is presented. Experiments in our lab suggest that B cell selection that would prevent self-reactivity and promote responsiveness to particles that activate B cells independent of T cells happens in the gut. The gut contains a lot of 'friendly' bacteria that constantly stimulate the immune system it contains. Our experiments suggest that this environment supports stages in B cell development that are largely ignored in models of human B cell immunology or assessment of human disease. We call this a 'checkpoint' because it is a stage of B cell development where only cells that have a required set of properties are allowed to pass. The gut is involved in the development of B cells in different ways in many species, including chickens, mice, sheep and rabbits. Therefore an influence of the gut on human B cell development is important and highly likely to occur, but as yet totally mysterious.The aims of experiments described in this application are to understand how B cells mature in the gut and how this is regulated.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41467-018-06089-1
发表时间:
2018-09-21
期刊:
Nature communications
影响因子:
16.6
作者:
[Zhao Y, Uduman M, Siu JHY, Tull TJ, Sanderson JD, Wu YB, Zhou JQ, Petrov N, Ellis R, Todd K, Chavele KM, Guesdon W, Vossenkamper A, Jassem W, D'Cruz DP, Fear DJ, John S, Scheel-Toellner D, Hopkins C, Moreno E, Woodman NL, Ciccarelli F, Heck S, Kleinstein SH, Bemark M, Spencer J]
通讯作者:
Spencer J
DOI:
10.1084/jem.20202001
发表时间:
2021-04-05
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Tull TJ, Pitcher MJ, Guesdon W, Siu JHY, Lebrero-Fernández C, Zhao Y, Petrov N, Heck S, Ellis R, Dhami P, Kadolsky UD, Kleeman M, Kamra Y, Fear DJ, John S, Jassem W, Groves RW, Sanderson JD, Robson MG, D'Cruz DP, Bemark M, Spencer J]
通讯作者:
Spencer J
Human intestinal lymphoid tissue in time and space.
时间和空间上的人体肠道淋巴组织。
DOI:
10.1038/s41385-018-0120-6
发表时间:
2019
期刊:
Mucosal immunology
影响因子:
8
作者:
[Spencer J]
通讯作者:
Spencer J
Checkpoint governing B cell fate decisions in human gut-associated lymphoid tissue.
-
批准号:MR/L009382/1
-
项目类别:Research Grant
-
资助金额:$48.11万
-
财政年份:2014
-
负责人:Jo Spencer
-
依托单位:
Generation of human intestinal IgA plasma cells: roles of innate and adaptive immunity.
-
批准号:BB/E000371/1
-
项目类别:Research Grant
-
资助金额:$44.15万
-
财政年份:2007
-
负责人:Jo Spencer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
-
批准号:2021JJ30609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:肖勇健
-
依托单位: